PMID: 11929563Apr 4, 2002Paper

Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections

Oral Microbiology and Immunology
T KuriyamaS Nakamura

Abstract

We recently reported the beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of 93 orofacial odontogenic infections. In this report, we determine the bacteriology and antimicrobial susceptibility of bacteria other than anaerobic gram-negative rods, mainly gram-positive cocci, isolated from the same specimens. Streptococcus constellatus and Peptostreptococcus micros were frequent isolates from all types of infection examined. Peptostreptococcus prevotii, Corynebacterium species, and Eubacterium species were recovered only from dentoalveolar infections, while Gemella morbillorum was found more frequently in periodontitis than in the other infections. beta-Lactamase-positive strains were detected only in staphylococci. Ampicillin, ampicillin/sulbactam, cefazolin, cefotaxime, imipenem, erythromycin, clindamycin and levofloxacin showed high susceptibility rates (> or = 77%) against viridans streptococci, Peptostreptococcus and Gemella. Minocycline showed a high MIC90 value against viridans streptococci (32 microg/ml), and metronidazole was effective against Peptostreptococcus and Gemella. These results provide useful information for the treatment of orofacial odontog...Continue Reading

References

Mar 1, 1977·The Journal of Infectious Diseases·S M Finegold
Aug 1, 1990·Oral Surgery, Oral Medicine, and Oral Pathology·Y Gill, C Scully
Nov 15, 2000·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·T KuriyamaS Nakamura

❮ Previous
Next ❯

Citations

Jun 6, 2003·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Jean-Louis SixouMartine Bonnaure-Mallet
Aug 6, 2005·Journal of Clinical Microbiology·Purnima S KumarEugene J Leys
Jan 1, 2012·Annals of Maxillofacial Surgery·Nagendra S ChunduriHaranadha Reddy
Dec 7, 2006·Scandinavian Journal of Infectious Diseases·Diamantis P KofteridisGeorgios Samonis
Feb 26, 2014·Journal of Endodontics·Francisco MontagnerBrenda Paula Figueiredo de Almeida Gomes
Nov 21, 2012·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Stuart E LieblichMichael J Zak
Oct 11, 2011·Oral and Maxillofacial Surgery Clinics of North America·Thomas R Flynn
Mar 31, 2016·Nigerian Journal of Clinical Practice·M JuncarF Onisor-Gligor
Aug 19, 2006·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Anthony J RegaVincent B Ziccardi
Aug 1, 2006·International Journal of Antimicrobial Agents·C Vreni MerriamEllie J C Goldstein
Jan 15, 2009·Journal of Medical Microbiology·D Robertson, A J Smith
Mar 3, 2019·Dentistry Journal·Mainul HaqueSeraj Zohurul Haque
May 30, 2013·The Journal of Craniofacial Surgery·Giada Anna BeltraminiAlessandro Baj
Jan 7, 2020·Avicenna Journal of Medicine·Dima YoussefMamta Sharma
Apr 9, 2019·The Journal of International Medical Research·Mihai JuncarFlorin Onisor-Gligor
Oct 9, 2004·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Panagiotis K Stefanopoulos, Alexandros E Kolokotronis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.